With the rising prevalence of chronic diseases worldwide, increased healthcare spending, favorable government policies and funding, and growing adoption of advanced technologies, demand for innovative drugs and treatments has been rising considerably, boosting the biotech industry’s outlook.
Given the industry tailwinds, it could be wise to invest in fundamentally sound biotech stocks Vertex Pharmaceuticals Incorporated (VRTX), Innoviva, Inc. (INVA), and Acorda Therapeutics, Inc. (ACOR) this week for solid returns.
